Journal article
Suicide risk in hepatitis C and during interferon‐alpha therapy: a review and clinical update
Abstract
Chronic hepatitis C (CHC) affects over 170 million individuals worldwide and is a growing public health concern. Despite the availability of CHC treatment, specifically interferon-α and ribavirin, treatment of CHC is limited by concerns about psychiatric side effects including risks of suicide. Although depression has been the focus of neuropsychiatric complications from interferon-alpha (IFNα), emerging evidence has contributed to our …
Authors
Sockalingam S; Links PS; Abbey SE
Journal
Journal of Viral Hepatitis, Vol. 18, No. 3, pp. 153–160
Publisher
Wiley
Publication Date
March 2011
DOI
10.1111/j.1365-2893.2010.01393.x
ISSN
1352-0504